Skip to main content
Third-party tested
Purity documentation available
Research supply chain
Compliance notice included
5-Amino-1MQ 50 mg research vial, Validated Peptides
99%+ Purity

Buy 5-Amino-1MQ

5-Amino-1MQ is a small molecule, not a peptide. It inhibits nicotinamide N-methyltransferase (NNMT), the enzyme that methylates nicotinamide using SAM as the methyl donor and sends the product, 1-methylnicotinamide, out of the NAD+ salvage pathway. In cultured adipocytes, methylquinolinium inhibitors of this class lowered 1-methylnicotinamide, raised intracellular NAD+ and SAM, and suppressed lipogenesis, and they did not inhibit the related SAM-dependent methyltransferases or the other salvage-pathway enzymes that were tested. That selectivity, plus membrane permeability measured in artificial-membrane and Caco-2 assays, is what makes the scaffold a practical bench tool. Researchers use it to ask what happens to NAD+ availability, methylation chemistry and adipocyte metabolism when NNMT is switched off rather than when NAD+ precursors are added.

1
$59.99
We accept

5-Amino-1MQ Certificate of Analysis

Third Party TestedLab Verifiable
Lab Verified3rd Party
99.9%
Purity
Passed full QC panel
Lot #5AM-50-CD-32
TestedNov 12, 2026
Full QC Panel
Purity (HPLC)99.9%
Net Peptide Content52.21mg
Identity (HPLC)Confirmed
Heavy Metals (ICP-MS)Pass
Microbial screen (PCR)No Growth
Endotoxin (USP <85>)NMT 0.05 EU/mL
Independent Lab Report
Lab Verified3rd Party
Pass
Identity
Lot #5AM-50-CD-32
TestedNov 12, 2026
Full QC Panel
Identity (HPLC)Confirmed
Independent Lab Report
Lab Verified3rd Party
52.21mg
Net Peptide Content
Lot #5AM-50-CD-32
TestedNov 12, 2026
Independent Lab Report
Lab Verified3rd Party
Pass
Fentanyl Screen
Lot #5AM-50-CD-32
TestedNov 12, 2026
Independent Lab Report
Lab Verified3rd Party
Pass
Heavy Metals
Lot #5AM-50-CD-32
TestedNov 12, 2026
Full QC Panel
Heavy Metals (ICP-MS)Pass
Independent Lab Report
Lab Verified3rd Party
Pass
Microbial Screen
Lot #5AM-50-CD-32
TestedNov 12, 2026
Full QC Panel
Microbial screen (PCR)No Growth
Independent Lab Report
Lab Verified3rd Party
Pass
Endotoxin
Lot #5AM-50-CD-32
TestedNov 12, 2026
Full QC Panel
Endotoxin (USP <85>)NMT 0.05 EU/mL
Independent Lab Report
Lab Verified3rd Party
99.9%
Purity
Passed full QC panel
Lot #5AM-50-CD-32
TestedNov 12, 2026
Full QC Panel
Purity (HPLC)99.9%
Net Peptide Content52.21mg
Identity (HPLC)Confirmed
Heavy Metals (ICP-MS)Pass
Microbial screen (PCR)No Growth
Endotoxin (USP <85>)NMT 0.05 EU/mL
Independent Lab Report
Lab Verified3rd Party
Pass
Identity
Lot #5AM-50-CD-32
TestedNov 12, 2026
Full QC Panel
Identity (HPLC)Confirmed
Independent Lab Report
Lab Verified3rd Party
52.21mg
Net Peptide Content
Lot #5AM-50-CD-32
TestedNov 12, 2026
Independent Lab Report
Lab Verified3rd Party
Pass
Fentanyl Screen
Lot #5AM-50-CD-32
TestedNov 12, 2026
Independent Lab Report
Lab Verified3rd Party
Pass
Heavy Metals
Lot #5AM-50-CD-32
TestedNov 12, 2026
Full QC Panel
Heavy Metals (ICP-MS)Pass
Independent Lab Report
Lab Verified3rd Party
Pass
Microbial Screen
Lot #5AM-50-CD-32
TestedNov 12, 2026
Full QC Panel
Microbial screen (PCR)No Growth
Independent Lab Report
Lab Verified3rd Party
Pass
Endotoxin
Lot #5AM-50-CD-32
TestedNov 12, 2026
Full QC Panel
Endotoxin (USP <85>)NMT 0.05 EU/mL
Independent Lab Report

5-Amino-1MQ Specifications

Structured specifications and handling data

Molecular profile

Technical specifications

Type:Small Molecule (NNMT Inhibitor)
CAS Number:685079-15-6
Molecular Weight:159.21 g/mol
Formula:C10H11N2+
PubChem Database
Storage requirements

Stability and handling

Lyophilized
Cold Storage
Light Sensitive
Storage TemperatureStore in a cool, dry place away from light; refrigerate at 2–8°C (36–46°F)
ReconstitutionSterile water or bacteriostatic water recommended
StabilityStable when stored properly; avoid repeated freeze-thaw cycles

Frequently researched together

Compounds commonly studied alongside this one.

NAD+
NAD+

500mg

$59.99

SS-31
SS-31

10mg

$89.99

5-Amino-1MQ research overview

NNMT takes nicotinamide, a form of vitamin B3, and attaches a methyl group to it using SAM (S-adenosylmethionine) as the donor. The product, 1-methylnicotinamide, cannot be recycled back into NAD+ through the salvage pathway, so an active NNMT drains two things at once: the nicotinamide a cell could have turned into NAD+, and the methyl groups it needs for everything else that uses SAM. 5-Amino-1MQ blocks the enzyme, so both pools stay fuller.

In 3T3-L1 adipocytes, inhibitors of this methylquinolinium series lowered 1-methylnicotinamide, raised intracellular NAD+ and SAM, and suppressed lipogenesis. The same work tested the compounds against structurally related methyltransferases and against the NAD+ salvage enzymes and found no inhibition, which is why the scaffold is used to attribute an effect specifically to NNMT rather than to methyl metabolism in general.

What NNMT itself responds to is also an active question. In cultured adipocytes, glucose deprivation doubled NNMT mRNA and protein, and AMPK activation or mTOR inhibition reproduced the effect, which places the enzyme downstream of the cell's own energy sensing. Animal work has gone in a different direction: in aged mice, NNMT inhibition raised grip strength, and the effect added to exercise rather than overlapping with it, and in a mouse model of hindlimb ischemia it improved muscle strength without changing perfusion or capillary density. Those are rodent and cell-culture endpoints, and the compound has no published human trials.

NNMT Enzyme Inhibition

Characterized against NNMT and, for selectivity, against related SAM-dependent methyltransferases and NAD+ salvage enzymes.

NAD+ Salvage Measurements

Adipocyte studies tracked intracellular NAD+ and the reaction product 1-methylnicotinamide after inhibition.

Methyl Donor Balance

Research has measured SAM levels, since the blocked reaction is the one that consumes the cell's methyl donor.

Skeletal Muscle Endpoints

Rodent studies have examined grip strength, fiber size and intramyocellular lipid content in aged and ischemic muscle.

5-Amino-1MQ Research Evidence

Published studies and concise summaries for research review.

Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice
Neelakantan H et al.

AI-generated summary of this research paper below.

The study that established this chemical series as a usable NNMT tool. Methylquinolinium analogs with a primary amine substitution crossed membranes in both passive and active transport assays, and they did not inhibit structurally related SAM-dependent methyltransferases or NAD+ salvage pathway enzymes. In cultured adipocytes the inhibitors lowered the NNMT reaction product 1-methylnicotinamide, raised intracellular NAD+ and SAM, and suppressed lipogenesis. In diet-induced obese mice, a potent analog reduced body weight, white adipose mass, adipocyte size and plasma total cholesterol with no change in food intake. The authors propose increased flux of NAD+ and SAM as the mechanism, which is the framing most later NNMT work builds on.
Research overview
Total Papers
100+
Year Range
2018+
Research status
Active
Peer-reviewed studies available
Research FAQ

5-Amino-1MQ FAQs

Concise answers about laboratory context, handling, and documentation for this compound.

Laboratory compliance notice

All compounds sold by Validated Peptides are intended for in-vitro laboratory research only.

These materials are not approved by the FDA for human or animal use and are not intended for diagnostic, therapeutic, or clinical applications.

Purchasers are responsible for compliant handling, storage, and use within an appropriate laboratory environment.

Research Use Only
Not for Human Use
21+ Required